The influence of sympathetic nervous activity on cardiac catecholamine levels.
D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology; D002714:Chlorisondamine / Q000494:pharmacology; D003080:Cold Temperature; D004336:Drug Antagonism; D004798:Enzymes / Q000494:pharmacology*; D004987:Ethers / Q000494:pharmacology; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006632:Histamine; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009206:Myocardium / Q000032:analysis*; D009281:Naphthalenes / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis*; D010293:Pargyline / Q000494:pharmacology; D010393:Pempidine / Q000494:pharmacology; D051381:Rats; D013564:Sympathetic Nervous System / Q000502:physiology*; D014316:Tritium; D014443:Tyrosine; D014992:Xylenes / Q000494:pharmacology
D001949:Bretylium Compounds; D004798:Enzymes; D004987:Ethers; D006584:Hexamethonium Compounds; D006834:Hydrazines; D008781:Methyltyrosines; D009281:Naphthalenes; D014992:Xylenes; D014316:Tritium; D014443:Tyrosine; D006632:Histamine; D010293:Pargyline; D002714:Chlorisondamine; D010393:Pempidine; D009638:Norepinephrine